45,487 Shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Acquired by Private Advisor Group LLC

Posted by Defense World Staff on Aug 27th, 2023

Private Advisor Group LLC purchased a new position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 45,487 shares of the pharmacy operator’s stock, valued at approximately $1,573,000.

A number of other large investors also recently added to or reduced their stakes in WBA. Exeter Financial LLC raised its holdings in shares of Walgreens Boots Alliance by 54.6% during the 1st quarter. Exeter Financial LLC now owns 25,168 shares of the pharmacy operator’s stock worth $909,000 after acquiring an additional 8,891 shares in the last quarter. Vanguard Personalized Indexing Management LLC raised its holdings in shares of Walgreens Boots Alliance by 10.4% during the 1st quarter. Vanguard Personalized Indexing Management LLC now owns 42,859 shares of the pharmacy operator’s stock worth $1,482,000 after acquiring an additional 4,024 shares in the last quarter. Zions Bancorporation N.A. raised its holdings in shares of Walgreens Boots Alliance by 39.0% during the 1st quarter. Zions Bancorporation N.A. now owns 109,552 shares of the pharmacy operator’s stock worth $3,788,000 after acquiring an additional 30,761 shares in the last quarter. South Dakota Investment Council raised its holdings in shares of Walgreens Boots Alliance by 0.6% during the 1st quarter. South Dakota Investment Council now owns 329,282 shares of the pharmacy operator’s stock worth $11,387,000 after acquiring an additional 2,000 shares in the last quarter. Finally, Vantage Consulting Group Inc raised its holdings in shares of Walgreens Boots Alliance by 20.6% during the 1st quarter. Vantage Consulting Group Inc now owns 20,415 shares of the pharmacy operator’s stock worth $706,000 after acquiring an additional 3,490 shares in the last quarter. 57.89% of the stock is owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Stock Performance

WBA opened at $25.26 on Friday. Walgreens Boots Alliance, Inc. has a 12-month low of $24.97 and a 12-month high of $42.29. The company has a debt-to-equity ratio of 0.30, a current ratio of 0.63 and a quick ratio of 0.32. The business’s fifty day simple moving average is $29.41 and its 200-day simple moving average is $32.21.

Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) last posted its quarterly earnings results on Tuesday, June 27th. The pharmacy operator reported $1.00 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.07). Walgreens Boots Alliance had a positive return on equity of 12.62% and a negative net margin of 2.44%. The firm had revenue of $35.42 billion for the quarter, compared to the consensus estimate of $34.32 billion. During the same period in the previous year, the company posted $0.96 EPS. Walgreens Boots Alliance’s quarterly revenue was up 8.6% compared to the same quarter last year. As a group, sell-side analysts expect that Walgreens Boots Alliance, Inc. will post 4 EPS for the current year.

Walgreens Boots Alliance Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 12th. Stockholders of record on Monday, August 21st will be given a dividend of $0.48 per share. This represents a $1.92 dividend on an annualized basis and a dividend yield of 7.60%. The ex-dividend date is Friday, August 18th. Walgreens Boots Alliance’s payout ratio is -50.00%.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on WBA. Deutsche Bank Aktiengesellschaft downgraded Walgreens Boots Alliance from a “buy” rating to a “hold” rating and cut their target price for the company from $46.00 to $34.00 in a research report on Wednesday, June 28th. Barclays cut their target price on Walgreens Boots Alliance from $38.00 to $32.00 in a research report on Wednesday, June 28th. UBS Group cut their target price on Walgreens Boots Alliance from $37.00 to $35.00 in a research report on Tuesday, June 27th. Morgan Stanley cut their target price on Walgreens Boots Alliance from $37.00 to $27.00 and set an “underweight” rating on the stock in a research report on Monday, July 3rd. Finally, JPMorgan Chase & Co. cut their target price on Walgreens Boots Alliance from $40.00 to $35.00 in a research report on Wednesday, June 28th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $37.00.

Check Out Our Latest Research Report on WBA

Insider Transactions at Walgreens Boots Alliance

In related news, EVP John Patrick Driscoll acquired 5,172 shares of the firm’s stock in a transaction that occurred on Friday, June 30th. The stock was purchased at an average cost of $28.42 per share, for a total transaction of $146,988.24. Following the purchase, the executive vice president now directly owns 59,050 shares of the company’s stock, valued at approximately $1,678,201. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 17.50% of the company’s stock.

Walgreens Boots Alliance Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.